1. Seropian I.M. [et al.]Inflammatory markers in ST-elevation acute myocardial infarction. // European Heart Journal. Acute Cardiovascular Care. - 2016 - Vol. 5 - №4. - P. 382-395
2. Passlick B., Flieger D., Ziegler-Heitbrock H.W. Identification and characterization of a novel monocyte subpopulation in human peripheral blood // Blood. - 1989. - Vol. 74. - P. 2527-2534.
3. Weber C. Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) Working Groups “Atherosclerosis & Vascular Biology” and “Thrombosis” // Thrombosis and Haemostasis. - 2016. - Vol. 116. - P. 626-637.
4. Nahrendorf M., Pittet M.J. Swirski F.K. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction // Circulation. - 2010. - Vol. 121.--№22. - P. 2437-2445.
5. Swirski F.K., Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure // Science. - 2013. -Vol. 339. - P. 161--166.
6. Tapp L.D. The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction // L.D. Tapp, E. Shantsila, B.J. Wrigley, B. Pamukcu et al. // Journal of thrombosis and Haemostasis. - 2012. - Vol. 10. - Is. 7. - P. 1231-1241.
7. Thygesen K. [et al.] Third universal definition of myocardial infarction. // European Heart Journal. - 2012. - Vol. 33. - P. 2551--2567.
8. Odegaard A.O. Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes // A.O. Odegaard, D.R. Jacobs, O.A. Sanchez, D.C. Goff Jr. et al. // Cardiovascular Diabetology. - 2016. - Vol. 15. - Is. 51. [Электронный ресурс] // URL.: https://doi.org/10.1186/s12933-016-0369-6
9. Mann D.L. [et al.] Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. - 10 Ed. - Elsevier Saunders. - 2015.
10. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD // European Heart Journal. - 2013. - Vol. 34. - Is. 39. - P. 3035-3087.
11. Diabetes propels the risk for cardiovascular disease: sweet monocytes becoming aggressive? J.A. van Diepen [et al.]// Cellular and Molecular Life Sciences - 2016 - Vol.73 - Is.24 - P.4675-4684.
12. Shirai T. [et al.] The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease. // The Journal of Experimental Medicine. - 2016. - Vol. 213. - Is. 3. - P. 337-354.